Prevagen

Reported Uses

• NOTE: see Herb & Supplement Effectiveness Rating Definitions table
• age-related cognitive decline [Insufficient Evidence]
• amyotrophic lateral sclerosis [Insufficient Evidence]
• cognitive function [Insufficient Evidence]
• insomnia [Insufficient Evidence]
• memory [Insufficient Evidence]

Reported Doses

Safety/efficacy may not be established; reported doses may be derived from limited or potentially inadequate studies with variable regimens, multi-ingredient products, or where concentration of active ingredients may vary widely

Special Note

[formulation clarification]

Info: uses and doses represent various apoaequorin-containing products; select proprietary products noted below

[Prevagen products]

Info: each capsule contains apoaequorin/cholecalciferol 10 mg/50 mcg, 20 mg/50 mcg, or 40 mg/50 mcg; each chewable tablet contains apoaequorin/cholecalciferol 10 mg/50 mcg or 20 mg/50 mcg; cholecalciferol 50 mcg = 2000 units

Effectiveness Ratings

[see Herb & Supplement Effectiveness Rating Definitions table]

age-related cognitive decline

[Insufficient Evidence]

Dose: 10 mg/50 mcg PO qd

amyotrophic lateral sclerosis

[Insufficient Evidence]

Dose: 20 mg/50 mcg PO q2-3h, then 20 mg/50 mcg or 40 mg/50 mcg PO qhs